Fellowship Director: Frederick R. Ueland, M.D.
The University of Kentucky Fellowship Program in Gynecologic Oncology is a fully accredited 3-year ABOG program, consisting of 12 months of research and 24 months of clinical experience. Upon completion of the fellowship, graduates will have the necessary skills to accept an academic position, evaluate and manage all patients with gynecologic malignancies, prescribe and manage chemotherapy, implement cancer education programs, perform meaningful translational research, participate in collaborative group trials, and assume a leadership role in cancer centers. A published thesis of original research is a requirement of all fellows.
The Division provides comprehensive cancer care for women from the Commonwealth of Kentucky and the surrounding region. Annual patient care volumes include: 5,000 outpatient visits, 1,300 chemotherapy cycles, 1,000 surgical cases, and 200 robotic-assisted procedures. The robust clinical volumes give fellows exposure to the procedures necessary to demonstrate competency in all aspects of gynecologic cancer care. Quality, safety, effectiveness, and ethical conduct are emphasized. The weekly, multi-disciplinary Tumor Conference integrates the principles of surgery, surgical pathology, radiation oncology and adjuvant treatment, and formalizes the gynecologic oncology components in the education of students, residents and fellows. The Division is a leader in the cancer center for participation on screening and therapeutic clinical trials, including investigator-initiated, collaborative group, and pharmaceutical trials. Over the past two years, publications have appeared in THE LANCET Oncology, Cancer, Obstetrics & Gynecology, Gynecologic Oncology, International Journal of Surgical Oncology, Neoplasia, Journal of Women’s Health, J. of Pediatric Surgery, Pathology, Cancer Investigation, AJOG, Clinical Obstetrics and Gynecology.
The Division of Gynecologic Oncology is an integral part of the NCI-designated Markey Cancer Center (MCC) at the University of Kentucky. Under the leadership of Dr. Mark Evers, the MCC has thrived and now includes scientists from 28 departments of eight different colleges at the University of Kentucky. The basic science and translational research has been classified into four formal programs: 1) Cancer Cell Biology and Signaling, 2) Cancer Prevention and Control, 3) Drug Discovery, Delivery and Translational Therapeutics, 4) and Redox Injury and Repair. The MCC consists of inpatient care facilities, outpatient clinics, the Outpatient Chemotherapy and Infusion unit, the CombsResearchBuilding, and the Whitney Hendrickson Women’s Cancer facility. The MCC also maintains a biospecimens core. Since its establishment in 1983, the MarkeyCancerCenter has experienced a steady increase in numbers of faculty, research programs, funding and space. In FY 2009 the Markey Cancer Center had more than $31M in funding, including over $25M in Federal funding, $10M+ from the National Cancer Institute and $6M+ of non-Federal funding. The MarkeyCancerCenter has a total center controlled research space of over a 150,000 net square feet. The center treats more than 2,000 new cancer patients each year and serves as one of the major cancer treatment and referral centers in the region. Research and affiliate networks have been established throughout the state and region to facilitate a state-wide impact in cancer care.